• Published 18 Apr 2024

CatSci to Attend Anglonordic Life Science Conference 2024

  • Events

CatSci Ltd, an award-winning innovation partner for medicines development, will be attending the Anglonordic Life Science Conference 2024, taking place in County Hall London on 18th April 2024. 

Akil Jacobs Holden, our Business Development Executive, will be attending Anglonordic London. He is looking forward to networking with the industry and discussing how CatSci can address your CMC challenges with our in-depth drug development expertise. Our capabilities span from preclinical through all phases of development, commercialisation and post approval changes across process chemistryGMP-analyticalHPAPIsmaterial sciences and preformulation, and oligonucleotides. From candidate selection through product launch and beyond, CatSci can de-risk your pharmaceutical pipeline and accelerate your path to clinic. 

If you would like to book a meeting with Akil to discuss how we’ve helped companies with their route scouting, process design & optimisation and scale-up needs, get in touch here.    

Resources & Insights

  • 11 May 2026
CatSci Achieves ISO 27001 Certification, Demonstrating its Commitment to Client Data Security
  • News
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB
  • 23 Mar 2026
HTE-Enabled Suzuki Optimisation for Cost Reduction
  • High Throughput Experimentation
  • HTE
  • Case Studies
244 KB
  • 23 Mar 2026
  • Sam Whitmarsh
From Experiment-Centric to Data-Centric Optimisation: Introducing CHETAH – The Digital Core of Smarter, Faster High-Throughput Experimentation
  • Digital
  • High-Throughput Experimentation
  • HTE
  • Thought Leaders